澳能（卤米松）联合他克莫司治疗局限型白癜风64例临床观察  

Clinical observation of 64 cases of vitiligo treated with

作　　者：程军民[1] CHENG Jun-min(Department of Dermatology,Donghai County Center for Disease Control and Prevention,Jiangsu Province,Jiangsu Lianyungang 222300)

机构地区：[1]江苏省东海县疾病预防控制中心皮肤性病科

出　　处：《临床医药文献电子杂志》2019年第74期3-4,共2页Electronic Journal of Clinical Medical Literature

摘　　要：目的探究使用卤米松联合他克莫司对于临床上治疗局限型白癜风所起到的效果。方法随机选取2013年1月~2016年12月在我中心进行治疗的白癜风患者64例作为研究对象,将其随机分为实验组和对照组,各32例,对照组患者使用他克莫司治疗,分别给予他克莫司2次/d,卤米松1次/d,卤米松采用隔日疗法。实验组患者使用卤米松联合他克莫司治疗,给予他克莫司与卤米松联合治疗,他克莫司2次/d,卤米松1次/d,卤米松采用隔日疗法。4个月后观察并对比两组患者的疗效。结果经过治疗,实验组患者总有效率为81.25%。对照组总有效率为68.76%。两组患者疗效对比,差异有统计学意义(P<0.05)。结论使用卤米松联合他克莫司治疗的实验组患者现实的疗效较好,且并无较大不良反应,值得临床推广使用。Objective To explore the effect of combination therapy with tacrolimus on clinical treatment of vitiligo.Methods Sixty-four patients with vitiligo treated in our hospital from January 2013 to December 2016 were divided into experimental group and control group.The patients in the control group were treated with tacrolimus.The patients in the experimental group The efficacy of the two groups of patients was observed and compared with tacrolimus for 3 months.Results After treatment,the total effective rate of the experimental group was 81.25%.The total effective rate of the control group was 68.76%.The difference between the two groups was statistically significant(P<0.05).Conclusion The efficacy of the combined use of methacloprate in the experimental group was better and had no adverse reaction and was worthy of clinical use.

关 键 词：卤米松 他克莫司 联合 白癜风 临床价值 

分 类 号：R785.41[医药卫生—口腔医学]